Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
Kenneth I ZhengWen-Yue LiuXiao-Yan PanHong-Lei MaPei-Wu ZhuXi-Xi WuGiovanni TargherChristopher ByrneXiao-Dong WangYong-Ping ChenFengmin LuMing-Hua ZhengPublished in: BMJ open diabetes research & care (2020)
NASH is highly prevalent in patients with NAFLD with persistent nALT levels. The G-NASH model accurately identifies NASH in this patient group.